BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | May 6, 2019
Distillery Therapeutics

The GJA1 inhibitor clofazimine to treat glioblastoma

BioCentury | Jan 21, 2013
Clinical News

Nexagon: Phase IIb data

BioCentury | Feb 2, 2012
Targets & Mechanisms

Closing the gap on liver toxicity

BioCentury | May 2, 2011
Finance

Anti-anti-wound healing

VCs double-down on CoDa's novel approach to wound healing
BioCentury | Apr 18, 2011
Financial News

CoDa raises $19.2 million

BioCentury | May 31, 2010
Clinical News

Nexagon: Phase II data

BioCentury | Feb 22, 2007
Financial News

CoDa raises $10 million

BioCentury | Oct 16, 2006
Finance

Ebb & Flow

BioCentury | Oct 12, 2006
Financial News

CoDa raises $10 million

Items per page:
1 - 10 of 10